Previous issue | Volume 92 | ESPE2019

58th Annual ESPE meeting

Vienna, Austria
19 Sep 2019 - 21 Sep 2019

Card image cap
The theme of this year’s meeting is Variety and Variation in Paediatric Endocrinology. Join us in Vienna to explore the diversity we encounter in our discipline and the care that we have to exercise when using the term “normality”. Whilst gaining an update on the latest treatments, clinical best practice and cutting edge research in the field of paediatric endocrinology.

Rapid Free Communications

Multi-system Endocrine Disorders

European Registries For Rare Endocrine Conditions (EuRRECa): Results From The Pilot Phase Of The Platform For e-Reporting Of Rare Endocrine Conditions (e-REC)
1Developmental Endocrinology Research Group, School of Medicine, Dentistry & Nursing, University of Glasgow, Glasgow, United Kingdom. 2Office for Rare Conditions, Royal Hospital for Children & Queen Elizabeth University Hospital, Glasgow, United Kingdom. 3MVLS College IT Services, University of Glasgow,, Glasgow, United Kingdom. 4Department of Internal Medicine and Paediatrics, Ghent University, Belgium, Department of Paediatric Endocrinology, Ghent University Hospital, Ghent, Belgium. 5Diabetes Center AUF DER BULT, Hannover, Germany. 6Genetics and Genomic Medicine Programme, UCL GOS Institute of Child Health, 30 Guilford Street, London, United Kingdom. 7Departments of Medicine & Clinical Epidemiology, Leiden University Medical Centre,, Leiden, Netherlands. 8Division of Paediatric Endocrinology and Diabetes, Department of Paediatrics and Adolescent Medicine, University of Lübeck, Lubeck, Germany. 9APHP, Bicêtre Paris Sud, le Kremlin Bicêtre, Paris, France. 10Sorbonne Université, Inserm, Centre de recherche Sainte Antoine, APHP, Hôpital des Enfants Armand Trousseau, Paris, France. 11Pediatric Endocrinology and Inborn Errors of Metabolism, Karolinska University Hospital, S-17176, Stockholm, Sweden. 12Clinical Genetics and Endocrinology Laboratory, Department of Laboratory Medicine, Semmelweis University, Budapest, Hungary. 13Dept of Medicine, Division of Endocrinology, Leiden University Medical Center, Leiden, Netherlands. 14Division of Endocrine and Metabolic Diseases, Istituto Auxologico Italiano, Milan, Italy. 15Dept of Clinical Sciences and Community Health, University of Milan, Milan, Italy. 16Med. Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany. 17Department of Pediatrics, Motol University Hospital, Prague, Czech Republic. 18National Centre for Rare Diseases, Istituto Superiore di Sanità, Rome, Italy. 19Erasmus Medical Centre, Department of Internal Medicine, Academic Centre for Thyroid Diseases, Rotterdam, Netherlands
hrp0092rfc3.1
Factors Affecting Loss to Follow-Up for Patients with Chronic Endocrine Conditions During the Pediatric Period: A Cohort Study at a Reference Center for Rare Diseases
1Robert Debré University Hospital, Paris, France. 2Endocrinology-Diabetology Department, Reference Center for endocrine growth and developmental diseases, Paris University, Paris, France. 3Clinical Epidemiology Unit, Paris, France
hrp0092rfc3.2
The Founder Homozygous NR5A1 Gene Mutation p.R103Q Causes Asplenia and Severe XY-DSD and XX-DSD in a Palestinian Cohort
1Division of Pediatric endocrinology, Palestine Red Crescent Society Hospital, Hebron, Palestine. 2Pediatric Urology Unit, Hadassah Hebrew University Medical Center, Jerusalem, Israel. 3Division of Pediatric Endocrinology, Hadassah Hebrew University Medical Center, Jerusalem, Israel. 4Neuropediatric Unit, Department of Pediatrics, Share Zedek Medical Center, Jerusalem, Israel. 5The Genetic Institute, Share Zedek Medical Center, Jerusalem, Israel
hrp0092rfc3.3
Peripheral Glucocorticoid Metabolim May Reflect Resolution of Inflammation in Kawasaki Disease
1Teine-Keijinkai Hospital, Sapporo, Japan. 2Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan. 3The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom
hrp0092rfc3.4
Evaluation of Endothelial Function in Childhood Standard Risk Acute Lymphoblastic Leukemia Survivors: Role of Subclinical Markers and Identification of Preventable Factors
1Pediatric Unit, Department of Medical and Surgical Sciences for Mothers, Children and Adults, University of Modena and Reggio Emilia, Modena, Italy. 2Oncology and Hematology Pediatric Unit, Department of Medical and Surgical Sciences for Mothers, Children and Adults, University of Modena and Reggio Emilia, Modena, Italy. 3Post Graduate School of Pediatrics, Department of Medical and Surgical Sciences for Mothers, Children and Adults, University of Modena and Reggio Emilia, Modena, Italy
hrp0092rfc3.5
Prevalence of Endocrine Complications in Duchenne Muscular Dystrophy
1Department of Endocrinology, Diabetes and Metabolism, University Children's Hospital, University Medical Centre Ljubljana, Ljubljana, Slovenia. 2Department of Paediatrics, Medical Faculty, University of Ljubljana, Ljubljana, Slovenia. 3Department of Child, Adolescent and Developmental Neurology, University Children's Hospital, University Medical Centre Ljubljana, Ljubljana, Slovenia
hrp0092rfc3.6